白芍总苷对代谢综合征-高血压大鼠改善胰岛素敏感性、降压和抗氧化作用

中国临床药理学与治疗学 ›› 2010, Vol. 15 ›› Issue (2): 154-159.

白芍总苷对代谢综合征-高血压大鼠改善胰岛素敏感性、降压和抗氧化作用

冯瑞儿¹, 郑琳颖², 吕俊华³, 潘竞锵⁴, 肖柳英⁴

¹广州医学院第二附属医院高级医疗服务中心,广州 510260,广东;
²广州市中医医院药剂科,广州 510130,广东;
³暨南大学药学院药理教研室,广州 510632,广东;
⁴广州市中医中药研究所药理研究室,广州 510130,广东

收稿日期:2009-11-24 修回日期:2009-12-29 出版日期:2010-02-26 发布日期:2020-09-18
通讯作者: 潘竞锵,男,主任药师,研究方向:治疗糖尿病及其慢性并发症以及胰岛素抵抗相关疾病药物的药理学研究。E-mail: pjq56@yahoo.com.cn
作者简介:冯瑞儿,女,主管技师,研究方向:心血管病电生理辅助检查及药理实验研究。Tel: 020-34152420
基金资助:
广东省医学科学技术基金(A2004546);广州市中医药中西医结合科研课题基金(2004A039)

Effects of total glucosides of paeong on improving insulin sensitivity, lowering blood pressure and enhancing antioxidation in metabolic syndrome-hypertensive rats

FENG Rui-er¹, ZHENG Lin-ying², LV Jun-hua³, PAN Jing-qiang⁴, XIAO Liu-ying⁴

¹ Advanced Medical Service Center, the Second Affilliated Hospital of Guangzhou Medical College, Guangzhou 510260, Guangdong, China;
² Department of Pharmacy, Guangzhou Hospital Traditional Chinese Medicine, Guangzhou 510130, Guangdong, China;
³ Department of Pharmacology, College of Pharmacy in Jinan University, Guangzhou 510632, Guangdong,China;
⁴ Department of Pharmacology, Guangzhou Institute of Traditional Chinese Medicine & Materia Medica, Guangzhou 510130, Guangdong,China

Received:2009-11-24 Revised:2009-12-29 Online:2010-02-26 Published:2020-09-18

摘要/Abstract

摘要： 目的:探讨白芍总苷(TGP)对代谢综合征-高血压(metabolic syndromic- hypertension, MS-Ht)大鼠血压的作用,检测胰岛素敏感性、细胞因子、血管活性物质以及氧化应激的改变,研究其作用机制。方法:采用高脂、高糖饮食喂饲SD大鼠,连续8周,当造模动物出现高血压、糖耐量减退,MS-Ht病理模型建立成功;然后将大鼠随机分为模型对照、二甲双胍(metformin, Met)200 mg/kg 和TGP 150、50 mg/kg 两个剂量组;分别灌胃给药或蒸馏水,qd×4周,实验结束时,测定大鼠血压、空腹血糖(FBG)和口服糖耐量试验 2 h 血糖(OGTT-2 hBG)、血浆胰岛素(Fins),并计算胰岛素敏感性(ISI)和胰岛素抵抗指数(HOMA-IRI);测定游离脂肪酸(FFA)、TNF-α、内皮素(ET-1)、肾素-血管紧张素(AngⅡ)、NO和丙二醛(MDA)含量以及一氧化氮合酶(NOS)和超氧化物歧化酶(SOD)活性。结果:与正常对照组比较,MS-Ht大鼠血压升高;FBG、OGTT-2hBG和Fins含量增高;ISI减弱、而HOMA-IRI增强;FFA、TNF-α、ET-1、肾素- AngⅡ和MDA含量增高(P<0.05 或P<0.01);NO含量和NOS及SOD活性降低(P<0.05 或P<0.01)。Met和TGP 150 mg/kg 增强ISI,而降低HOMA-IRI,纠正高胰岛素血症(P<0.05 或P<0.01),降低FFA、TNF-α、ET-1、肾素-AngⅡ和MDA含量(P<0.05 或P<0.01),提高NO含量和NOS及SOD活性;而Met能降低FBG、OGTT-2 h BG含量(P<0.05 或P<0.01);与TGP 150 mg/kg 组比较,差异无统计学意义(P>0.05);TGP 50 mg/kg 组,除降低肾素、AngⅡ和 FFA含量外(P<0.05),对其余指标,差异均无统计学意义(P>0.05)。结论:TGP和Met能对抗MS-Ht大鼠胰岛素抵抗、增强胰岛素敏感性、纠正高胰岛素血症,拮抗ET-1、肾素- AngⅡ系统和氧化应激反应,提高NO和NOS功能,降低血压;TGP不具直接降血糖作用,与Met不同。TGP以上效应呈量效关系。

关键词: 白芍总苷, 代谢综合征, 高血压, 胰岛素抵抗, 肾素-血管紧张素系统, TNF-α, 血管活性物质, 大鼠

Abstract: AIM: To investigate the antihypertensive effects and effective mechanisms of total glucosides of paeong(TGP for short)on insulin resistance, hypertension,and the changes of oxidative stress in metabolic syndromic(MS)-hypertensive(Ht)rats. METHODS: The SD rats were fed with a high fat(25%)-sucrose (10%)-enriched diet qd for 8 weeks. When the rats were exposed hypertension and impaired glucose tolerance (IGT),and the rats were randomly divided into normal control group, metformin (Met) group 200 mg/kg, and TGP 150, 50 mg/kg, solvent or the drugs were adiministered by intragastric administration (i.g.) qd for 4 weeks. The blood pressure (BP), the contents of fasting blood glucose (FBG), 2-hours blood glucose after oral glucose tolerance test (2 h BG-OGTT), and fasting insulin (Fins) were determined, as well as the insulin sensitivity index (ISI) and insulin resistance index (HOMA-IRI) were calculated; the contents of free fatty acids (FFA), TNF-α, endothelin (ET-1), renin-angiotensinⅡ, NO,malonaldehyde (MDA) and activities of nitric oxide synthase (NOS) and superoxide dismutase (SOD) activity were determined after treatment. RESULTS: Compared with normal control group,the BP and the contents of FBG,OGTT-2 h BG,Fins were incresaed in MS-Ht rats,and ISI was weaken, HOMA-IRI was incresaed. the contents of FFA,TNF-α,ET-1,renin-Ang Ⅱ,MDA were incresaed;the content of NO,the activities of NOS and SOD were decreased(P<0.05 or P<0.01). The ISI was incresaed,the HOMA-IRI was decreased,retrieve hyperinsulinemia(P<0.05 or P<0.01), the contents of FFA,TNF-α,ET-1,renin-Ang Ⅱ,MDA were decreased,the activities of NO,NOS,SOD were elevated in Met group and TGP 150 mg/kg group. Compared with TGP 150 mg/kg group,the contents of FBG,OGTT-2 h BG were decreased in Met group,there was no significant difference. CONCLUSION: TGP and Met are able to enhance the insulin sensitivity, retrieve hyperinsulinemia,Antagonism of ET-1, renin-Ang Ⅱ system and oxidative stress response,augment the function of NO, NOS, degrade the BP;TGP does not have a strong predominance against hyperglycaemia, TGP differs from Met. The effects of TGP show dose-effect relationship.

Key words: Total glucosides of paeong, Metabolic syndrome, Hypertension, Insulin resistance, Rennin-angiotensin system, TNF-α, Vasoactive substance, Rat

中图分类号:

R965.2

冯瑞儿, 郑琳颖, 吕俊华, 潘竞锵, 肖柳英. 白芍总苷对代谢综合征-高血压大鼠改善胰岛素敏感性、降压和抗氧化作用[J]. 中国临床药理学与治疗学, 2010, 15(2): 154-159.

FENG Rui-er, ZHENG Lin-ying, LV Jun-hua, PAN Jing-qiang, XIAO Liu-ying. Effects of total glucosides of paeong on improving insulin sensitivity, lowering blood pressure and enhancing antioxidation in metabolic syndrome-hypertensive rats[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 154-159.

参考文献

[1] You D, Cochain C, Loinard C, et al.Insulin resistance as the underlying cause for the metabolic syndrome[J]. J Pharmacol Exp Ther, 2008,325(3):766-773.
[2] Cheung B. Hypertension as part of the metabolic syndrome[J].J Hum Hypertens,2008,22(12): 871-874.
[3] Kim CH, Younossi ZM. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome[J]. Cleve Clin J Med,2008,75(10): 721-728.
[4] Paschos P, Paletas K.Non alcoholic fatty liver disease and metabolic syndrome[J]. Hippokratia,2009,13(1): 9-19.
[5] 郑琳颖,潘竞锵,吕俊华.白芍总苷对脂肪肝大鼠增强胰岛素敏感性及抗脂肪肝作用[J].中国中药杂志, 2008,33(20):2385-2390.
[6] 郑琳颖,潘竞锵,吕俊华.白芍总苷增强高脂血症-胰岛素抵抗大鼠胰岛素敏感性和降血脂作用研究[J].时珍国医国药, 2008,19(2):349-351.
[7] Matveyenko AV, Gurlo T, Daval M, et al. Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced beta-cell endoplasmic reticulum stress[J]. Diabetes,2009,58(4):906-916.
[8] Olatunji LA, Soladoye AO. Increased magnesium intake prevents hyperlipidemia and insulin resistance and reduced lipid peroxidation in fructose-fed rats[J]. Pathophysiology,2007, 14(1):11-15.
[9] Kamari Y, Harari A, Shaish A, et al. Effect of telmisartan, angiotensin II receptor antagonist, on metabolic profile in fructose-induced hypertensive, hyperinsulinemic, hyperlipidemic rats[J]. Hypertens Res,2008, 31(1):135-140.
[10] Rajasekar P, Viswanathan P, Anuradha CV. Beneficial impact of L-carnitine in liver: a study in a rat model of syndrome X[J].Amino Acids, 2008,5(2):475-483.
[11] Rabe K, Lehrke M, Parhofer KG, et al. Adipokines and insulin resistance[J]. Mol Med, 2008,14(11/12): 741-751.
[12] Han SH, Sakuma I, Shin EK, et al. Anti- atherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies[J]. Prog Cardiovasc Dis,2009,52(2): 126-140.
[13] Han SH, Quon MJ, Koh KK. Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction[J]. Curr Opin Lipidol,2007,18(1):58-65.
[14] Jiang B, Qiao J, Yang Y, et al. Inhibitory effect of paeoniflorin on the inflammatory vicious cycle between adipocytes and macrophages[J]. J Cell Biochem,2009 Apr 24. [Epub ahead of print]
[15] Henriksen EJ. Improvement of insulin sensitivity by antagonism of the renin-angiotensin system[J]. Am J Physiol Regul Integr Comp Physiol, 2007,293(3):R974-R980.
[16] 陈康,窦京涛,潘长玉.血管紧张素Ⅱ、炎性反应和2型糖尿病[J].国际内科学杂志,2008,35 (12):699-704.
[17] Androulakis ES, Tousoulis D, Papageorgiou N, et al. Essential hypertension: is there a role for inflammatory mechanisms[J] ?Cardiol Rev, 2009,17(5):216-221.
[18] Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, et al. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats[J]. Hypertension, 2005,46(4):943-947.
[19] Wu Y, Ren K, Liang C, et al. Renoprotective effect of total glucosides of paeony (TGP) and its mechanism in experimental diabetes[J]. J Pharmacol Sci, 2009,109(1):78-87.
[20] Su J, Zhang P, Zhang JJ, et al. Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats[J]. Phytomedicine, 2009 Sep 14. [Epub ahead of print]
[21] Zhang P, Zhang JJ, Su J, et al. Effect of total glucosides of paeony on the expression of nephrin in the kidneys from diabetic rats[J]. Am J Chin Med, 2009,37(2):295-307.
[22] 苏静,吴永贵,张晶晶,等.白芍总苷对糖尿病大鼠肾组织JAK/STAT信号通路的调节作用[J]. 中国现代医学杂志, 2009,19(3):362-366.
[23] 陈碧莲,刘慧霞,潘瑞喆. 葡萄糖耐量减低患者二甲双胍干预治疗的临床效果[J].中国临床药理学与治疗学,2007,12(1):107-110.
[24] 李红辉,刘恩波,谢群,等.罗格列酮与二甲双胍对2型糖尿病患者血压的影响[J].中国临床药理学与治疗学, 2005,10(6):717-720.
[25] Papanas N, Maltezos E, Mikhailidis DP. Metformin: diamonds are forever[J]. Expert Opin Pharmacother, 2009,10(15):2395-2397.